Myopia

• EMA approval · 2026-07-22
  EMA Authorised: Ryjunea (atropine sulfate) — Santen Oy

  EMA authorised Ryjunea (atropine sulfate) for myopia, marketed by Santen Oy.

• EMA approval · 2025-09-11
  EMA Authorised: Ryjunea (atropine sulfate) — Santen Oy

  The EMA authorised Ryjunea (atropine sulfate) from Santen Oy for myopia, with decision date 02/06/2025.